SF 4541

Introduction - 94th Legislature (2025 - 2026)

Posted on 04/10/2026 03:11 p.m.

A bill for an act
relating to cannabis; modifying cannabis business licensing provisions; establishing
a cannabis macrobusiness license; amending Minnesota Statutes 2024, sections
342.01, subdivisions 14, 52, 54; 342.09, subdivision 3; 342.175; 342.22,
subdivisions 1, 5; 342.27, subdivision 12; 342.35, subdivision 1; 342.37, subdivision
1; 342.41, subdivision 1; 342.51, by adding subdivisions; 342.515, as amended;
342.61, subdivision 5; 342.63, subdivision 4; 342.80; Minnesota Statutes 2025
Supplement, sections 342.01, subdivision 48; 342.10; 342.11; 342.12; 342.13;
342.18, subdivision 2; 342.22, subdivision 3; 342.40, subdivision 7; 342.51,
subdivision 2; 342.61, subdivision 4; 342.63, subdivisions 2, 3, 6; repealing
Minnesota Statutes 2024, section 342.51, subdivision 1.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2024, section 342.01, subdivision 14, is amended to read:

Subd. 14.

Cannabis business.

"Cannabis business" means any of the following licensed
under this chapter:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service; and

(11) deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end .

Sec. 2.

Minnesota Statutes 2025 Supplement, section 342.01, subdivision 48, is amended
to read:

Subd. 48.

License holder.

"License holder" means a person, cooperative, or business
that holds any of the following licenses:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible wholesaler;

(13) lower-potency hemp edible retailer; or

(14) deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end .

Sec. 3.

Minnesota Statutes 2024, section 342.01, subdivision 52, is amended to read:

Subd. 52.

Medical cannabinoid product.

(a) "Medical cannabinoid product" means a
new text begin cannabis new text end product that deleted text begin :
deleted text end

deleted text begin (1) consists of or contains cannabis concentrate or hemp concentrate or is infused with
cannabinoids, including but not limited to artificially derived cannabinoids; and
deleted text end

deleted text begin (2) deleted text end is provided to a patient enrolled in the registry program; new text begin a visiting patient; new text end a registered
designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a
registered designated caregiver, cannabis retailer, or cannabis business with a medical
cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical
condition.

deleted text begin (b) A medical cannabinoid product must be in the form of:
deleted text end

deleted text begin (1) liquid, including but not limited to oil;
deleted text end

deleted text begin (2) pill;
deleted text end

deleted text begin (3) liquid or oil for use with a vaporized delivery method;
deleted text end

deleted text begin (4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
deleted text end

deleted text begin (5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and
sublingual tablets;
deleted text end

deleted text begin (6) edible products in the form of gummies and chews;
deleted text end

deleted text begin (7) topical formulation; or
deleted text end

deleted text begin (8) any allowable form or delivery method approved by the office.
deleted text end

deleted text begin (c) Medical cannabinoid product does not include adult-use cannabis products or
hemp-derived consumer products.
deleted text end

new text begin (b) A medical cannabinoid product may contain hemp concentrate or may be infused
with cannabinoids derived from hemp. A medical cannabinoid product is not subject to
potency limits established by the office in rule.
new text end

Sec. 4.

Minnesota Statutes 2024, section 342.01, subdivision 54, is amended to read:

Subd. 54.

Medical cannabis flower.

"Medical cannabis flower" means cannabis flower
provided to a patient enrolled in the registry program or a visiting patient; a registered
designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a
registered designated caregiver, cannabis retailer, or cannabis business with a medical
cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical
condition. deleted text begin Medical cannabis flower does not include adult-use cannabis flower.
deleted text end

Sec. 5.

Minnesota Statutes 2024, section 342.09, subdivision 3, is amended to read:

Subd. 3.

Home extraction of cannabis concentrate by use of volatile solvent
prohibited.

No person may use a volatile solvent to separate or extract cannabis concentrate
or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, new text begin cannabis
macrobusiness, new text end cannabis manufacturer, deleted text begin medical cannabis combination business, deleted text end or
lower-potency hemp edible manufacturer license issued under this chapter.

Sec. 6.

Minnesota Statutes 2025 Supplement, section 342.10, is amended to read:

342.10 LICENSES; TYPES.

The office shall issue the following types of license:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible wholesaler;

(13) lower-potency hemp edible retailer; and

(14) deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end .

Sec. 7.

Minnesota Statutes 2025 Supplement, section 342.11, is amended to read:

342.11 LICENSES; FEES.

(a) The office shall require the payment of application fees, initial licensing fees, and
renewal licensing fees as provided in this section. The initial license fee shall include the
fee for initial issuance of the license and the first annual renewal. The renewal fee shall be
charged at the time of the second renewal and each subsequent annual renewal thereafter.
Nothing in this section prohibits a local unit of government from charging the retailer
registration fee established in section 342.22. Application fees, initial licensing fees, and
renewal licensing fees are nonrefundable.

(b) Application and licensing fees shall be as follows:

(1) for a cannabis microbusiness:

(i) an application fee of $500;

(ii) an initial license fee of $0; and

(iii) a renewal license fee of $2,000;

(2) for a cannabis mezzobusiness:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(3) for a cannabis cultivator:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $30,000;

(4) for a cannabis manufacturer:

(i) an application fee of $10,000;

(ii) an initial license fee of $10,000; and

(iii) a renewal license fee of $20,000;

(5) for a cannabis retailer:

(i) an application fee of $2,500;

(ii) an initial license fee of $2,500; and

(iii) a renewal license fee of $5,000;

(6) for a cannabis wholesaler:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(7) for a cannabis transporter:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(8) for a cannabis testing facility:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(9) for a cannabis delivery service:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(10) for a cannabis event organizer:

(i) an application fee of $750; and

(ii) an initial license fee of $750;

(11) for a lower-potency hemp edible manufacturer:

(i) an application fee of $250;

(ii) an initial license fee of $1,000; and

(iii) a renewal license fee of $1,000;

(12) for a lower-potency hemp edible wholesaler:

(i) an application fee of $250;

(ii) an initial license fee of $10,000; and

(iii) a renewal license fee of $10,000;

(13) for a lower-potency hemp edible retailer:

(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than
one retail location, $250 per retail location;

(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more
than one retail location, $250 per retail location; and

(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more
than one retail location, $250 per retail location; and

(14) for a deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end :

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $70,000.

Sec. 8.

Minnesota Statutes 2025 Supplement, section 342.12, is amended to read:

342.12 LICENSES; TRANSFERS; ADJUSTMENTS.

(a) Licenses issued under this chapter that are available to all applicants pursuant to
section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior
written approval of the office unless the license holder has not received a final site inspection
or the license holder is a social equity applicant.

(b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision
1b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another
social equity applicant for three years after the date on which the office issues the license.
Three years after the date of issuance, a license holder may transfer a license to any entity.
Transfer of a license that was issued as a social equity license must be reviewed by the
Division of Social Equity and is subject to the prior written approval of the office.

(c) Preliminary license approval issued pursuant to section 342.14, subdivision 5, may
not be transferred.

(d) A new license must be obtained when:

(1) the form of the deleted text begin licensee's deleted text end new text begin license holder's new text end legal business structure converts or changes
to a different type of legal business structure; or

(2) the deleted text begin licensee deleted text end new text begin license holder new text end dissolves; consolidates; reorganizes; undergoes bankruptcy,
insolvency, or receivership proceedings; merges with another legal organization; or assigns
all or substantially all of its assets for the benefit of creditors.

(e) Licenses must be renewed annually.

(f) deleted text begin License holders may petition the office to adjust the tier of a license issued within a
license category if the license holder meets all applicable requirements deleted text end new text begin Beginning January
1, 2027, the office may determine whether licenses are available for a license holder that is
a cannabis microbusiness or cannabis mezzobusiness to reclassify the license holder as
another type of business, either as a cannabis mezzobusiness or cannabis macrobusiness.
Applicants for cannabis macrobusiness licenses are subject to the requirements of section
342.18. If the office determines that licenses are available subject to section 342.14,
subdivision 1a, the office must announce the number of available cannabis mezzobusiness
licenses and cannabis macrobusiness licenses and the date on which the office will begin
accepting petitions from applicants seeking reclassification. When approving reclassification
of a license, the office must give priority to: (1) any cannabis microbusiness with a medical
retail endorsement that is seeking reclassification; or (2) any cannabis mezzobusiness with
a medical endorsement that is seeking reclassification. The number of reclassified licenses
available to social equity applicants must be equal to or greater than the number of
reclassified licenses available to all applicants. A license holder that seeks to reclassify its
license as a cannabis mezzobusiness or cannabis macrobusiness must include in its application
a transition plan that describes how the license holder will comply with all statutes and rules
applicable to the reclassified license. Reclassification according to this paragraph must not
remove the social equity license status from a social equity license new text end .

(g) The office by rule may permit the relocation of a licensed cannabis business; permit
the relocation of an approved operational location, including a cultivation, manufacturing,
processing, or retail location; adopt requirements for the submission of a license relocation
application; establish standards for the approval of a relocation application; and charge a
fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed
premises pursuant to this paragraph does not extend or otherwise modify the license term
of the license subject to relocation.

Sec. 9.

Minnesota Statutes 2025 Supplement, section 342.13, is amended to read:

342.13 LOCAL CONTROL.

(a) A local unit of government may not prohibit the possession, transportation, or use
of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived
consumer products authorized under this chapter.

(b) Except as provided in section 342.22, a local unit of government may not prohibit
the establishment or operation of a cannabis business or hemp business licensed under this
chapter.

(c) A local unit of government may adopt reasonable restrictions on the time, place, and
manner of the operation of a cannabis business provided that such restrictions do not prohibit
the establishment or operation of cannabis businesses. A local unit of government may
prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a
day care, residential treatment facility, or an attraction within a public park that is regularly
used by minors, including a playground or athletic field.

(d) The office shall work with local units of government to:

(1) develop model ordinances for reasonable restrictions on the time, place, and manner
of the operation of a cannabis business;

(2) develop standardized forms and procedures for the issuance of a retail registration
pursuant to section 342.22; and

(3) develop model policies and procedures for the performance of compliance checks
required under section 342.22.

(e) If a local unit of government is conducting studies or has authorized a study to be
conducted or has held or has scheduled a hearing for the purpose of considering adoption
or amendment of reasonable restrictions on the time, place, and manner of the operation of
a cannabis business, the governing body of the local unit of government may adopt an
interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting
the planning process and the health, safety, and welfare of its citizens. Before adopting the
interim ordinance, the governing body must hold a public hearing. The interim ordinance
may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction
or a portion thereof until January 1, 2025.

(f) Within 30 days of receiving a copy of an application from the office, a local unit of
government shall certify on a form provided by the office whether a proposed cannabis
business complies with local zoning ordinances and, if applicable, whether the proposed
business complies with the state fire code and building code. The office may not issue a
license if the local unit of government informs the office that the cannabis business does
not meet local zoning and land use laws. If the local unit of government does not provide
the certification to the office within 30 days of receiving a copy of an application from the
office, the office may issue a license.

(g) The office by rule shall establish an expedited complaint process to receive, review,
and respond to complaints made by a local unit of government about a cannabis business.
At a minimum, the expedited complaint process shall require the office to provide an initial
response to the complaint within seven days and perform any necessary inspections within
30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a
local ordinance. If a local unit of government notifies the office that a cannabis business
other than a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness new text begin , cannabis
macrobusiness, new text end or lower-potency hemp edible retailer with a retail operations endorsement deleted text begin ,
or medical cannabis combination business operating a retail location deleted text end poses an immediate
threat to the health or safety of the public, the office must respond within one business day
and may take any action described in section 342.19 or 342.21.

(h) A local government unit that issues a cannabis retailer registration under section
342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis
mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with
a retail operations endorsement to no fewer than one registration for every 12,500 residents.

(i) If a county has one active registration for every 12,500 residents, a city or town within
the county is not obligated to register a cannabis business.

(j) Nothing in this section shall prohibit a local government unit from allowing licensed
cannabis retailers in excess of the minimums set in paragraph (h).

(k) Notwithstanding the foregoing provisions, the state shall not issue a license to any
cannabis business to operate in Indian country, as defined in United States Code, title 18,
section 1151, of a Minnesota Tribal government without the consent of the Tribal
government.

Sec. 10.

Minnesota Statutes 2024, section 342.175, is amended to read:

342.175 SOCIAL EQUITY LICENSE CLASSIFICATION.

(a) The office must classify licenses listed in section 342.10, clauses (1) to (10) and deleted text begin (13) deleted text end new text begin
(14) new text end as:

(1) available to social equity applicants who meet the requirements of section 342.17;
and

(2) available to all applicants.

(b) The office must classify any license issued to a social equity applicant as a social
equity license.

Sec. 11.

Minnesota Statutes 2025 Supplement, section 342.18, subdivision 2, is amended
to read:

Subd. 2.

Vertical integration prohibited; exceptions.

(a) Except as otherwise provided
in this subdivision, the office shall not issue licenses to a single applicant that would result
in the applicant being vertically integrated in violation of the provisions of this chapter.

(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses,
mezzobusiness licenses, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end licenses,
or the issuance of lower-potency hemp edible manufacturer, lower-potency hemp edible
wholesaler, and lower-potency hemp edible retailer licenses to the same person or entity.

Sec. 12.

Minnesota Statutes 2024, section 342.22, subdivision 1, is amended to read:

Subdivision 1.

Registration required.

Before making retail sales to customers or patients,
a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, deleted text begin medical deleted text end cannabis
deleted text begin combination business deleted text end new text begin macrobusiness new text end , or lower-potency hemp edible retailer must register
with the city, town, or county in which the retail establishment is located. A county may
issue a registration in cases where a city or town has provided consent for the county to
issue the registration for the jurisdiction.

Sec. 13.

Minnesota Statutes 2025 Supplement, section 342.22, subdivision 3, is amended
to read:

Subd. 3.

Issuance of registration.

(a) A local unit of government shall issue a retail
registration to a cannabis microbusiness with a retail operations endorsement, cannabis
mezzobusiness with a retail operations endorsement, cannabis retailer, deleted text begin medical deleted text end cannabis
deleted text begin combination business deleted text end new text begin macrobusiness new text end operating a retail location, or lower-potency hemp
edible retailer that:

(1) has a valid license or preliminary license approval issued by the office;

(2) has paid the registration fee or renewal fee pursuant to subdivision 2;

(3) is found to be in compliance with the requirements of this chapter at any preliminary
compliance check that the local unit of government performs; and

(4) if applicable, is current on all property taxes and assessments at the location where
the retail establishment is located.

(b) Before issuing a retail registration, the local unit of government may conduct a
preliminary compliance check to ensure that the cannabis business or hemp business is in
compliance with any applicable local ordinance established pursuant to section 342.13.

(c) A local unit of government shall renew the retail registration of a cannabis business
or hemp business when the office renews the license of the cannabis business or hemp
business.

(d) A retail registration issued under this section may not be transferred.

Sec. 14.

Minnesota Statutes 2024, section 342.22, subdivision 5, is amended to read:

Subd. 5.

Registration suspension and cancellation; notice to office; penalties.

(a) If
a local unit of government determines that a cannabis business or hemp business with a
retail registration issued by the local unit of government is not operating in compliance with
the requirements of a local ordinance authorized under section 342.13 or that the operation
of the business poses an immediate threat to the health or safety of the public, the local unit
of government may suspend the retail registration of the cannabis business or hemp business.
The local unit of government must immediately notify the office of the suspension and shall
include a description of the grounds for the suspension.

(b) The office shall review the retail registration suspension and may order reinstatement
of the retail registration or take any action described in section 342.19 or 342.21.

(c) The retail registration suspension must be for up to 30 days unless the office suspends
the license and operating privilege of the cannabis business or hemp business for a longer
period or revokes the license.

(d) The local unit of government may reinstate the retail registration if the local unit of
government determines that any violation has been cured. The local unit of government
must reinstate the retail registration if the office orders reinstatement.

(e) No cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, deleted text begin medical deleted text end
cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end , or lower-potency hemp edible retailer may
make any sale to a customer or patient without a valid retail registration with a local unit
of government and a valid license with any applicable endorsement from the office. A local
unit of government may impose a civil penalty of up to $2,000 for each violation of this
paragraph.

Sec. 15.

Minnesota Statutes 2024, section 342.27, subdivision 12, is amended to read:

Subd. 12.

Prohibitions.

A cannabis business with a license or endorsement authorizing
the retail sale of cannabis flower or cannabis products shall not:

(1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived
consumer products to a person who is visibly intoxicated;

(2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles,
or hemp-derived consumer products than a customer is legally permitted to possess;

(3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products;

(4) operate a drive-through window;

(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products in vending machines; deleted text begin or
deleted text end

(6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer
knows that any required security or statewide monitoring systems are not operational deleted text begin . deleted text end new text begin ; or
new text end

new text begin (7) sell medical cannabinoid products to a person who is not registered in the patient
registry or is not enrolled in the registry program as a patient or caregiver.
new text end

Sec. 16.

Minnesota Statutes 2024, section 342.35, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis transporter license entitles the license
holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis
products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, new text begin cannabis macrobusinesses, new text end cannabis cultivators,
cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers,
and industrial hemp growers to cannabis microbusinesses, cannabis mezzobusinesses,
new text begin cannabis macrobusinesses, new text end cannabis manufacturers, cannabis testing facilities, cannabis
wholesalers, cannabis retailers, new text begin and new text end lower-potency hemp edible retailers deleted text begin , and medical
cannabis combination businesses deleted text end and perform other actions approved by the office.

Sec. 17.

Minnesota Statutes 2024, section 342.37, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis testing facility license entitles the license
holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis
products, hemp plant parts, hemp concentrate, artificially derived cannabinoids,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, new text begin cannabis macrobusinesses, new text end cannabis cultivators,
cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers,
deleted text begin medical cannabis combination businesses, deleted text end and industrial hemp growers.

Sec. 18.

Minnesota Statutes 2025 Supplement, section 342.40, subdivision 7, is amended
to read:

Subd. 7.

Cannabis event sales.

(a) Cannabis microbusinesses with a retail endorsement,
cannabis mezzobusinesses with a retail endorsement, cannabis retailers, deleted text begin medical deleted text end cannabis
deleted text begin combination businesses deleted text end new text begin macrobusinesses new text end operating a retail location, and lower-potency
hemp edible retailers, including the cannabis event organizer, may be authorized to sell
cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products to customers at a cannabis event.

(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must
take place in a retail area as designated in the premises diagram.

(c) Authorized retailers may only conduct sales within their specifically assigned area.

(d) Authorized retailers must verify the age of all customers pursuant to section 342.27,
subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis
flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer
products to an individual under 21 years of age.

(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use
cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived
consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis
products must be stored in a sample jar or display case and be accompanied by a label or
notice containing the information required to be affixed to the packaging or container
containing adult-use cannabis flower and adult-use cannabis products sold to customers. A
sample may not consist of more than eight grams of adult-use cannabis flower or adult-use
cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams
of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use
cannabis flower or adult-use cannabis product before purchase.

(f) The notice requirements under section 342.27, subdivision 6, apply to authorized
retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,
and hemp-derived consumer products for sale at a cannabis event.

(g) Authorized retailers may not:

(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products to a person who is visibly intoxicated;

(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, or hemp-derived consumer products than a customer
is legally permitted to possess;

(3) sell medical cannabis flower or medical cannabinoid products; or

(4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products in vending machines.

(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis
product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis
plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,
and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,
locked container that is not accessible to the public. Such items being stored at a cannabis
event shall not be left unattended.

(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis
event must comply with this chapter and rules adopted pursuant to this chapter regarding
the testing, packaging, and labeling of those items.

(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,
damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring
system.

Sec. 19.

Minnesota Statutes 2024, section 342.41, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis delivery service license entitles the
license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles,
and hemp-derived consumer products from licensed cannabis microbusinesses with a retail
endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and
deleted text begin medical deleted text end cannabis deleted text begin combination businesses deleted text end new text begin macrobusinesses new text end ; transport and deliver cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumable
products to customers; and perform other actions approved by the office.

Sec. 20.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
read:

new text begin Subd. 1a. new text end

new text begin Types of medical cannabis endorsements; authorized actions. new text end

new text begin The office
may issue the following types of medical cannabis endorsements to a license holder:
new text end

new text begin (1) a medical cannabis cultivation endorsement;
new text end

new text begin (2) a medical cannabis manufacturer endorsement; or
new text end

new text begin (3) a medical cannabis retail endorsement.
new text end

Sec. 21.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
read:

new text begin Subd. 1b. new text end

new text begin Medical cannabis cultivation endorsement. new text end

new text begin (a) A cannabis microbusiness,
cannabis mezzobusiness, cannabis macrobusiness, or cannabis cultivator with a cannabis
cultivation endorsement may apply for and obtain a medical cannabis cultivation
endorsement.
new text end

new text begin (b) A cannabis business with a medical cannabis cultivation endorsement must:
new text end

new text begin (1) comply with the requirements of section 342.25; and
new text end

new text begin (2) otherwise meet all applicable requirements established by the office.
new text end

new text begin (c) A medical cannabis cultivation endorsement entitles the license holder to perform
the actions authorized in section 342.30, subdivision 1.
new text end

new text begin (d) A cannabis microbusiness with a medical cannabis cultivation endorsement may
cultivate cannabis in an additional 1,000 square feet indoors or one-quarter acre outdoors
in addition to the limits in section 342.28.
new text end

new text begin (e) A cannabis mezzobusiness with a medical cannabis cultivation endorsement may
cultivate cannabis in an additional 3,000 square feet indoors or one-half acre outdoors in
addition to the limits in section 342.29.
new text end

new text begin (f) A cannabis cultivator with a medical cannabis cultivation endorsement may cultivate
an additional 6,000 square feet indoors or one acre outdoors in addition to the limits in
section 342.30.
new text end

new text begin (g) Annually, at least one quarter of all cannabis flower cultivated by a cannabis business
with a medical cannabis cultivation endorsement must be sold by the license holder to a
cannabis business with a medical cannabis endorsement, including the license holder if the
license holder has a medical cannabis manufacturing endorsement or medical cannabis retail
endorsement.
new text end

Sec. 22.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
read:

new text begin Subd. 1c. new text end

new text begin Medical cannabis manufacturer endorsement. new text end

new text begin (a) A cannabis microbusiness,
cannabis mezzobusiness, cannabis macrobusiness, or cannabis manufacturer with a
manufacturing endorsement may apply for and obtain a medical cannabis manufacturer
endorsement.
new text end

new text begin (b) A cannabis business with a medical cannabis manufacturer endorsement must:
new text end

new text begin (1) comply with the requirements of section 342.26;
new text end

new text begin (2) manufacture high medical needs products identified by the office; and
new text end

new text begin (3) otherwise meet all applicable requirements established by the office.
new text end

new text begin (c) A medical cannabis manufacturer endorsement entitles a license holder to:
new text end

new text begin (1) manufacture medical cannabinoid products; and
new text end

new text begin (2) sell medical cannabinoid products only to other cannabis businesses with a medical
cannabis manufacturer endorsement or medical cannabis retail endorsement.
new text end

new text begin (d) A medical cannabinoid product must be labeled with a "Minnesota Medical Cannabis"
warning symbol and must only be sold to a person, patient, or caregiver enrolled in the
registry program or a visiting patient.
new text end

new text begin (e) A medical cannabis manufacturer endorsement held by a cannabis microbusiness
entitles the license holder to increase the use of cannabis by dry weight up to 25 percent
above the limit established by the office in rule.
new text end

new text begin (f) A medical cannabis manufacturer endorsement held by a cannabis mezzobusiness
entitles the license holder to increase the use of cannabis by dry weight up to 25 percent
above the limit established by the office in rule.
new text end

Sec. 23.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
read:

new text begin Subd. 1d. new text end

new text begin Medical cannabis retail endorsement. new text end

new text begin (a) A cannabis microbusiness, cannabis
mezzobusiness, cannabis macrobusiness, or cannabis retailer with a retail operations
endorsement may apply for and obtain a medical cannabis retail endorsement.
new text end

new text begin (b) A cannabis business with a medical cannabis retail endorsement must:
new text end

new text begin (1) comply with all requirements of this section and section 342.27;
new text end

new text begin (2) have at least one member of staff who has earned a medical cannabis consultant
certificate issued by the office and completed the required training or have at least one
member of staff who is a licensed pharmacist under chapter 151;
new text end

new text begin (3) ensure availability of patient consultations as required under this section;
new text end

new text begin (4) ensure that patients and caregivers enrolled in the registry program receive priority
service;
new text end

new text begin (5) carry all products identified by the office as high medical need; and
new text end

new text begin (6) otherwise meet all applicable requirements established by the office.
new text end

new text begin (c) The office must identify high medical need products and publish a list of all high
medical need products on the office's publicly accessible website.
new text end

new text begin (d) A medical cannabis retail endorsement held by a cannabis business entitles the license
holder to perform the actions authorized in section 342.32, subdivision 1.
new text end

new text begin (e) A cannabis microbusiness with a medical retail endorsement may operate one
additional retail location in excess of the limit in section 342.28, subdivision 2, paragraph
(d), if at least one retail location is located in an area identified by the office as a high medical
need area.
new text end

new text begin (f) A cannabis mezzobusiness with a medical cannabis retail endorsement may operate
two additional retail locations in excess of the limit in section 342.29, subdivision 2,
paragraph (d), if at least the retail locations are located in an area identified by the office as
a high medical need area.
new text end

new text begin (g) A cannabis retailer with a medical cannabis retail endorsement may operate up to
three additional retail locations in excess of the limit established in section 342.32,
subdivision 2, if the retail locations are located in an area identified by the office as a high
medical need area.
new text end

Sec. 24.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to
read:

new text begin Subd. 1e. new text end

new text begin Additional authorized actions; external transporter endorsement and
medical cannabis delivery endorsement. new text end

new text begin (a) A cannabis microbusiness or cannabis
mezzobusiness with at least two medical cannabis endorsements may apply for and obtain
an external transporter endorsement to transport immature cannabis plants and seedlings,
cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts,
hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer products to
other cannabis and hemp businesses if the cannabis business:
new text end

new text begin (1) provides the office with the information required in section 342.35, subdivision 2;
and
new text end

new text begin (2) complies with the requirements of section 342.36.
new text end

new text begin (b) A cannabis business with a medical cannabis retail endorsement may apply for and
obtain a medical cannabis delivery endorsement to deliver medical cannabis flower and
medical cannabinoid products to patients enrolled in the registry program; registered
designated caregivers; and parents, legal guardians, and spouses of an enrolled patient if
the cannabis business:
new text end

new text begin (1) provides the office with the information required in section 342.41, subdivision 2;
and
new text end

new text begin (2) complies with the requirements of subdivisions 2 and 3 and section 342.42.
new text end

Sec. 25.

Minnesota Statutes 2025 Supplement, section 342.51, subdivision 2, is amended
to read:

Subd. 2.

Distribution requirements.

deleted text begin (a) deleted text end Prior to distribution of medical cannabis flower
or medical cannabinoid products to a person enrolled in the registry program, an employee
of a cannabis business must:

(1) review and confirm the patient's enrollment in the registry program;

(2) verify that the person requesting the distribution of medical cannabis flower or
medical cannabinoid products is the patient deleted text begin , deleted text end new text begin ; new text end the patient's registered designated caregiver deleted text begin , deleted text end new text begin ; new text end
or the patient's parent, legal guardian, or spouse using the procedures established by the
office;

(3) confirm that the patient had a consultation with new text begin : new text end (i) an employee with a valid medical
cannabis consultant certificate issued by the office; or (ii) an employee who is a licensed
pharmacist under chapter 151 to determine the proper medical cannabis flower or medical
cannabinoid product, dosage, and paraphernalia for the patient if required under subdivision
3;

(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
product that includes recommended dosage requirements and other information as required
by the office; and

(5) provide the patient with any other information required by the office.

deleted text begin (b) A cannabis business with a medical cannabis retail endorsement may not deliver
medical cannabis flower or medical cannabinoid products to a person enrolled in the registry
program unless the cannabis business with a medical cannabis retail endorsement also holds
a cannabis delivery service license. The delivery of medical cannabis flower and medical
cannabinoid products are subject to the provisions of section 342.42.
deleted text end

Sec. 26.

Minnesota Statutes 2024, section 342.515, as amended by Laws 2025, chapter
31, sections 89 and 90, is amended to read:

342.515 deleted text begin MEDICAL deleted text end CANNABIS deleted text begin COMBINATION BUSINESSES deleted text end new text begin
MACROBUSINESSES new text end .

Subdivision 1.

Authorized actions.

deleted text begin (a) A person, cooperative, or business holding a
medical cannabis combination business license is prohibited from owning or operating any
other cannabis business or hemp business or holding an active registration agreement under
section 152.25, subdivision 1.
deleted text end

deleted text begin (b) A person or business may hold only one medical cannabis combination business
license.
deleted text end

deleted text begin (c) deleted text end new text begin (a) new text end A deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end license new text begin , consistent with
the requirements of specific license endorsements approved by the office, new text end entitles the license
holder to perform deleted text begin any or all of deleted text end the following deleted text begin within the limits established by this section deleted text end new text begin
actions new text end :

(1) grow cannabis plants from seed or immature plant to mature plant deleted text begin and deleted text end new text begin , new text end harvest
adult-use cannabis flower and medical cannabis flower from a mature plant new text begin , package and
label cannabis flower for sale to other cannabis businesses, and sell immature cannabis
plants and seedlings and cannabis flower to other cannabis businesses new text end ;

(2) make cannabis concentrate;

(3) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(4) manufacture artificially derived cannabinoids;

deleted text begin (5) manufacture medical cannabinoid products;
deleted text end

deleted text begin (6) deleted text end new text begin (5) new text end manufacture new text begin , package, and label new text end adult-use cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products for public consumption;

deleted text begin (7) deleted text end new text begin (6) new text end purchase immature cannabis plants and seedlings and cannabis flower from a
cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis
wholesaler, or another deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end ;

deleted text begin (8) deleted text end new text begin (7) new text end purchase hemp plant parts and propagules from an industrial hemp grower licensed
under chapter 18K;

deleted text begin (9) deleted text end new text begin (8) new text end purchase cannabis concentrate, hemp concentrate, and artificially derived
cannabinoids from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis
manufacturer, a cannabis wholesaler, or another deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin
macrobusiness new text end ;

deleted text begin (10) deleted text end new text begin (9) new text end purchase hemp concentrate from an industrial hemp processor licensed under
chapter 18K;

deleted text begin (11) manufacture, package, and label medical cannabis flower and medical cannabinoid
products for sale to cannabis businesses with a medical cannabis processor endorsement,
cannabis businesses with a medical cannabis retail endorsement, other medical cannabis
combination businesses, and persons in the registry program;
deleted text end

deleted text begin (12) transport and deliver medical cannabis flower and medical cannabinoid products
to medical cannabis processors, medical cannabis retailers, other medical cannabis
combination businesses, patients enrolled in the registry program, registered designated
caregivers, and parents, legal guardians, and spouses of an enrolled patient;
deleted text end

deleted text begin (13) manufacture, package, and label adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, and hemp-derived consumer products for sale to
customers and other cannabis businesses;
deleted text end

deleted text begin (14) sell medical cannabis flower and medical cannabinoid products to other cannabis
businesses with a medical endorsement, other medical cannabis combination businesses,
and patients enrolled in the registry program, registered designated caregivers, and parents,
legal guardians, and spouses of an enrolled patient;
deleted text end

deleted text begin (15) deleted text end new text begin (10) new text end sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law deleted text begin to other cannabis businesses and deleted text end to customers;

deleted text begin (16) transport immature cannabis plants and seedlings, adult-use cannabis flower,
adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer products,
and other products authorized by law to other cannabis businesses;
deleted text end

deleted text begin (17) deleted text end new text begin (11) new text end sell deleted text begin and transport deleted text end lower-potency hemp edibles to lower-potency hemp edible
retailers and lower-potency hemp edible wholesalers; and

deleted text begin (18) deleted text end new text begin (12) new text end perform other actions approved by the office.

deleted text begin (d) A medical cannabis combination business is not required to obtain a medical cannabis
endorsement to perform any actions authorized under this section.
deleted text end

new text begin (b) A cannabis macrobusiness must apply for and obtain a medical manufacturing
endorsement and at least one other medical cannabis endorsement identified in section
342.51.
new text end

Subd. 2.

Cultivation new text begin endorsement new text end ; size limitations.

new text begin (a) A cannabis macrobusiness
seeking to cultivate cannabis plants and harvest cannabis flower must obtain a cannabis
cultivation endorsement and comply with section 342.25.
new text end

new text begin (b) A cannabis macrobusiness that obtains a cannabis cultivation endorsement must
apply for and obtain a medical cannabis cultivation endorsement and comply with section
342.51, subdivision 1b.
new text end

deleted text begin (a) deleted text end new text begin (c) new text end A deleted text begin medical deleted text end cannabis deleted text begin combination business may cultivate cannabis to be sold as
medical cannabis flower or used in medical cannabinoid products in an area of up to 60,000
square feet of plant canopy subject to the limits on adult-use cannabis cultivation in paragraph
(c). A medical cannabis combination business may cultivate cannabis and manufacture
cannabis in more than one location, except the aggregate total of plant canopy in all locations
must count toward the business' canopy limit. deleted text end new text begin macrobusiness that cultivates cannabis at an
indoor facility may cultivate up to 45,000 square feet of plant canopy.
new text end

deleted text begin (b) deleted text end new text begin (d) new text end A deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end deleted text begin may cultivate cannabis to be sold as
adult-use cannabis flower or used in adult-use cannabis products in an area authorized by
the office as described in paragraph (c). deleted text end new text begin macrobusiness that cultivates cannabis at an outdoor
location may cultivate up to four acres of mature, flowering plants.
new text end

deleted text begin (c) The office shall authorize a medical cannabis combination business to cultivate
cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half
of the area the business used to cultivate cannabis sold in the medical market in the preceding
year. The office shall establish an annual verification and authorization procedure. The
office may increase the area of plant canopy in which a medical cannabis combination
business is authorized to cultivate cannabis for sale in the adult-use market between
authorization periods if the business demonstrates a significant increase in the sale of medical
cannabis and medical cannabis products.
deleted text end

new text begin (e) A cannabis macrobusiness with a cannabis cultivation endorsement and a retail
operations endorsement may package and label adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, and hemp-derived consumer products for sale to
customers.
new text end

new text begin (f) A cannabis macrobusiness with a medical cannabis cultivation endorsement and a
medical cannabis retail endorsement may package and label medical cannabis flower and
medical cannabinoid products for sale to patients enrolled in the registry program; registered
designated caregivers; and parents, legal guardians, and spouses of an enrolled patient.
new text end

Subd. 3.

deleted text begin Manufacturing deleted text end new text begin Manufacturer endorsement new text end ; size limitations.

new text begin (a) By rule,
new text end the office may establish limits on cannabis manufacturing that are consistent with the area
of plant canopy a business is authorized to cultivate. new text begin Until the office establishes limits by
rule, a cannabis macrobusiness must not use more than 90,000 pounds of cannabis or its
dry-weight equivalent of raw concentrates to manufacture cannabis products.
new text end

new text begin (b) A cannabis macrobusiness must apply for and obtain a medical cannabis manufacturer
endorsement and must comply with section 342.51, subdivision 1c.
new text end

new text begin (c) A cannabis macrobusiness may apply for and obtain one or more cannabis
manufacturer endorsements identified in section 342.26.
new text end

Subd. 4.

Retail new text begin operations new text end new text begin endorsement; new text end locations.

new text begin (a) new text end A deleted text begin medical deleted text end cannabis deleted text begin combination
business deleted text end new text begin macrobusiness with a retail operations endorsement new text end may operate up to deleted text begin one retail
location in each congressional district. A medical cannabis combination business must offer
medical cannabis flower, medical cannabinoid products, or both at every retail location. deleted text end new text begin
eight retail locations and, if operating more than five retail locations, must ensure that at
least three retail locations are located in areas identified by the office as high medical need
areas.
new text end

new text begin (b) A cannabis macrobusiness may apply for and obtain a retail operations endorsement
and must comply with section 342.27.
new text end

new text begin (c) A cannabis macrobusiness with a retail operations endorsement must apply for and
obtain a medical cannabis retail operations endorsement and comply with section 342.51,
subdivision 1d.
new text end

new text begin (d) A cannabis macrobusiness with a retail operations endorsement and a medical cannabis
retail operations endorsement must carry and make available for sale, at each retail location,
all high medical need products identified by the office.
new text end

Subd. 5.

Failure to participate; suspension or revocation of license.

The office may
suspend or revoke a deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end license if the
office determines that the business is no longer actively participating in the medical cannabis
market. deleted text begin The office may, by rule, establish minimum requirements related to cannabis
cultivation, manufacturing of medical cannabinoid products, retail sales of medical cannabis
flower and medical cannabinoid products, and other relevant criteria to demonstrate active
participation in the medical cannabis market. deleted text end new text begin If a cannabis macrobusiness fails to obtain or
operate under a medical cannabis manufacturer endorsement or fails to carry and make
available for sale, at each retail location, high medical need products identified by the office,
the office may suspend or revoke the cannabis macrobusiness's license under this subdivision.
new text end

deleted text begin Subd. 6. deleted text end

deleted text begin Operations. deleted text end

deleted text begin A medical cannabis combination business must comply with the
relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.
deleted text end

Subd. 7.

deleted text begin Transportation deleted text end new text begin Internal transporter endorsement new text end .

new text begin (a) new text end A deleted text begin medical deleted text end cannabis
deleted text begin combination business deleted text end new text begin macrobusiness new text end may new text begin obtain an internal transporter endorsement to new text end
transport immature cannabis plants and seedlings, cannabis flower, cannabis products,
artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp
edibles, and hemp-derived consumer products new text begin between facilities owned by the license holder new text end
if the deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end :

(1) provides the office with the information described in section 342.35, subdivision 2;
and

(2) complies with the requirements of section 342.36.

new text begin (b) A cannabis macrobusiness with at least two medical cannabis endorsements may
apply for and obtain an external transporter endorsement to transport immature cannabis
plants and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids,
hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived
consumer products to other cannabis and hemp businesses if the cannabis macrobusiness:
new text end

new text begin (1) provides the office with the information required under section 342.35, subdivision
2; and
new text end

new text begin (2) complies with the requirements of section 342.36.
new text end

new text begin (c) A cannabis macrobusiness with a medical cannabis endorsement is not required to
obtain an external transporter endorsement to transport immature cannabis plants and
seedlings, cannabis flower, cannabis products, lower-potency hemp edibles, hemp-derived
consumer products, medical cannabis flower, and medical cannabinoid products to a cannabis
testing facility.
new text end

new text begin Subd. 8. new text end

new text begin Multiple licenses. new text end

new text begin (a) A person, cooperative, or business holding a cannabis
macrobusiness license may also hold a cannabis event organizer license.
new text end

new text begin (b) Except as provided in paragraph (a), a person, cooperative, or business holding a
cannabis macrobusiness license is prohibited from owning or operating any other cannabis
business or hemp business or holding more than one cannabis macrobusiness license.
new text end

new text begin (c) For purposes of this subdivision, a restriction on the number or type of licenses that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.
new text end

new text begin Subd. 9. new text end

new text begin Conversion of licenses. new text end

new text begin (a) By January 1, 2027, the office must convert any
existing medical cannabis combination business licenses to cannabis macrobusiness licenses.
new text end

new text begin (b) Beginning January 1, 2028, the office may determine the number of available cannabis
macrobusiness licenses for applicants who do not have an existing license under this chapter.
The office must make the determination under this paragraph according to the requirements
of section 342.14, subdivision 1a. If the office is accepting applications for cannabis
macrobusiness licenses from applicants without an existing license under this chapter, the
office must announce the number of cannabis macrobusiness licenses available and the date
on which applications will be accepted. The number of licenses available to social equity
applicants must be equal to or greater than the number of licenses available to all applicants.
Applicants for cannabis macrobusiness licenses must comply with the application and
licensing requirements of this chapter.
new text end

Sec. 27.

Minnesota Statutes 2025 Supplement, section 342.61, subdivision 4, is amended
to read:

Subd. 4.

Testing of samples; disclosures.

(a) On a schedule determined by the office,
every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end shall
make each batch of cannabis flower, cannabis products, artificially derived cannabinoids,
lower-potency hemp edibles, or hemp-derived consumer products grown, manufactured, or
imported by the cannabis business or hemp business available to a cannabis testing facility.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end must
disclose all known information regarding pesticides, fertilizers, solvents, or other foreign
materials, including but not limited to catalysts used in creating artificially derived
cannabinoids, applied or added to the batch of cannabis flower, cannabis products, artificially
derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products
subject to testing. Disclosure must be made to the cannabis testing facility and must include
information about all applications by any person, whether intentional or accidental.

(c) A deleted text begin cannabis business deleted text end new text begin license holder new text end shall select one or more representative samples
from each batch, test the samples for the presence of contaminants, and test the samples for
potency and homogeneity and to allow the cannabis flower, cannabis product, artificially
derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be
accurately labeled with its cannabinoid profile. Testing for contaminants must include testing
for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide
residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include
testing for other contaminants. A cannabis testing facility must destroy or return to the
deleted text begin cannabis business or hemp business deleted text end new text begin license holder new text end any part of the sample that remains after
testing.

Sec. 28.

Minnesota Statutes 2024, section 342.61, subdivision 5, is amended to read:

Subd. 5.

Test results.

(a) If a sample meets the applicable testing standards, a cannabis
testing facility shall issue a certification to a cannabis microbusiness, cannabis
mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an
endorsement to import products, lower-potency hemp edible manufacturer, or deleted text begin medical deleted text end
cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end and the cannabis business or hemp business
may then sell or transfer the batch of cannabis flower, cannabis products, artificially derived
cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products from which
the sample was taken to another cannabis business or hemp business, or offer the cannabis
flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products
for sale to customers or patients. If a sample does not meet the applicable testing standards
or if the testing facility is unable to test for a substance identified pursuant to subdivision
4, paragraph (b), the batch from which the sample was taken shall be subject to procedures
established by the office for such batches, including destruction, remediation, or retesting.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end must
maintain the test results for cannabis flower, cannabis products, artificially derived
cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products grown,
manufactured, or imported by that cannabis business or hemp business for at least five years
after the date of testing.

(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end shall
make test results maintained by that cannabis business or hemp business available for review
by any member of the public, upon request. Test results made available to the public must
be in plain language.

Sec. 29.

Minnesota Statutes 2025 Supplement, section 342.63, subdivision 2, is amended
to read:

Subd. 2.

Content of label; cannabis.

All cannabis flower and hemp-derived consumer
products that consist of hemp plant parts sold to customers or patients must have affixed
on the packaging or container of the cannabis flower or hemp-derived consumer product a
label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end , or industrial
hemp grower where the cannabis flower or hemp plant part was cultivated;

(2) the net weight of cannabis flower or hemp plant parts in the package or container;

(3) the batch number;

(4) the cannabinoid profile;

(5) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(6) verification that the cannabis flower or hemp plant part was tested according to
section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
standards;

(7) information on the usage of the cannabis flower or hemp-derived consumer product;

(8) the following statement: "Keep this product out of reach of children."; and

(9) any other statements or information required by the office.

Sec. 30.

Minnesota Statutes 2025 Supplement, section 342.63, subdivision 3, is amended
to read:

Subd. 3.

Content of label; cannabinoid products.

(a) All cannabis products,
lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other
than products subject to the requirements under subdivision 2, medical cannabinoid products,
and hemp-derived topical products sold to customers or patients must have affixed to the
packaging or container of the cannabis product a label that contains at least the following
information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end , or industrial
hemp grower that cultivated the cannabis flower or hemp plant parts used in the cannabis
product, lower-potency hemp edible, hemp-derived consumer product, or medical
cannabinoid product;

(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis manufacturer, lower-potency hemp edible manufacturer, deleted text begin medical deleted text end cannabis
deleted text begin combination business deleted text end new text begin macrobusiness new text end , or industrial hemp grower that manufactured the
cannabis concentrate, hemp concentrate, or artificially derived cannabinoid and, if different,
the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis manufacturer, lower-potency hemp edible manufacturer, or deleted text begin medical deleted text end cannabis
deleted text begin combination business deleted text end new text begin macrobusiness new text end that manufactured the product;

(3) the net weight of the cannabis product, lower-potency hemp edible, or hemp-derived
consumer product in the package or container;

(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
product;

(5) the batch number;

(6) the serving size;

(7) the cannabinoid profile per serving and in total;

(8) a list of ingredients;

(9) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(10) a warning symbol developed by the office in consultation with the commissioner
of health and the Minnesota Poison Control System that:

(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;

(ii) is in a highly visible color;

(iii) includes a visual element that is commonly understood to mean a person should
stop;

(iv) indicates that the product is not for children; and

(v) includes the phone number of the Minnesota Poison Control System;

(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
consumer product, or medical cannabinoid product was tested according to section 342.61
and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
or medical cannabinoid product complies with the applicable standards;

(12) information on the usage of the product;

(13) the following statement: "Keep this product out of reach of children."; and

(14) any other statements or information required by the office.

(b) The office may by rule establish alternative labeling requirements for lower-potency
hemp edibles that are imported into the state if those requirements provide consumers with
information that is substantially similar to the information described in paragraph (a).

Sec. 31.

Minnesota Statutes 2024, section 342.63, subdivision 4, is amended to read:

Subd. 4.

Additional content of label; medical cannabis flower and medical
cannabinoid products.

In addition to the applicable requirements for labeling under
subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must
include at least the following information on the label affixed to the packaging or container
of the medical cannabis flower or medical cannabinoid product:

(1) the patient's name and date of birth;

(2) new text begin if applicable, new text end the name and date of birth of the patient's registered designated caregiver
or, if listed on the registry verification, the name of the patient's parent, legal guardian, or
spouse deleted text begin , if applicable deleted text end ; and

(3) the patient's registry identification number.

Sec. 32.

Minnesota Statutes 2025 Supplement, section 342.63, subdivision 6, is amended
to read:

Subd. 6.

Additional information.

(a) A cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end must provide
customers and patients with the following information:

(1) factual information about impairment effects and the expected timing of impairment
effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products;

(2) a statement that customers and patients must not operate a motor vehicle or heavy
machinery while under the influence of cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products;

(3) resources customers and patients may consult to answer questions about cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products, and any side effects and adverse effects;

(4) contact information for the poison control center and a safety hotline or website for
customers to report and obtain advice about side effects and adverse effects of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products;

(5) substance use disorder treatment options; and

(6) any other information specified by the office.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or deleted text begin medical deleted text end
cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end may include the information described in
paragraph (a) by:

(1) including the information on the label affixed to the packaging or container of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products;

(2) posting the information in the premises of the cannabis microbusiness, cannabis
mezzobusiness, cannabis retailer, or deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end ;
or

(3) providing the information on a separate document or pamphlet provided to customers
or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency
hemp edible, or a hemp-derived consumer product.

Sec. 33.

Minnesota Statutes 2024, section 342.80, is amended to read:

342.80 LAWFUL ACTIVITIES.

(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing,
and selling of cannabis flower, cannabis products, artificially derived cannabinoids,
lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis
business or hemp business in conformity with the rights granted by a cannabis business
license or hemp business license is lawful and may not be the grounds for the seizure or
forfeiture of property, arrest or prosecution, or search or inspections except as provided by
this chapter.

(b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, deleted text begin medical deleted text end cannabis deleted text begin combination business deleted text end new text begin macrobusiness new text end , or lower-potency
hemp edible retailer who sells or otherwise transfers cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products to a person under 21 years
of age is not subject to arrest, prosecution, or forfeiture of property if the person complied
with section 342.27, subdivision 4, and any rules promulgated pursuant to this chapter.

Sec. 34. new text begin REVISOR INSTRUCTION.
new text end

new text begin The revisor of statutes must renumber Minnesota Statutes, section 342.515, as section
342.295 and make any necessary cross-reference changes consistent with this renumbering.
new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective January 1, 2027.
new text end

Sec. 35. new text begin REPEALER.
new text end

new text begin Minnesota Statutes 2024, section 342.51, subdivision 1, new text end new text begin is repealed.
new text end

APPENDIX

Repealed Minnesota Statutes: 26-08065

342.51 MEDICAL CANNABIS ENDORSEMENTS.

Subdivision 1.

Endorsement; authorized actions.

(a) The office may issue a medical cannabis endorsement to a cannabis business authorizing the business to:

(1) cultivate medical cannabis;

(2) process medical cannabinoid products; or

(3) sell or distribute medical cannabis flower and medical cannabinoid products to any person authorized to receive medical cannabis flower or medical cannabinoid products.

(b) The office must issue a medical cannabis cultivation endorsement to a cannabis license holder if the license holder:

(1) is authorized to cultivate cannabis;

(2) submits a medical cannabis endorsement application to the office; and

(3) otherwise meets all applicable requirements established by the office.

(c) A medical cannabis cultivation endorsement entitles the license holder to grow cannabis plants within the approved amount of space from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical cannabis endorsement, and perform other actions approved by the office.

(d) The office must issue a medical cannabis processor endorsement to a cannabis license holder if the license holder:

(1) is authorized to manufacture cannabis products;

(2) submits a medical cannabis endorsement application to the office; and

(3) otherwise meets all applicable requirements established by the office.

(e) A medical cannabis processor endorsement entitles the license holder to:

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from cannabis businesses with a medical cannabis cultivator endorsement or a medical cannabis processor endorsement;

(2) purchase hemp plant parts from industrial hemp growers;

(3) make cannabis concentrate from medical cannabis flower;

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(5) manufacture medical cannabinoid products;

(6) package and label medical cannabinoid products for sale to cannabis businesses with a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and

(7) perform other actions approved by the office.

(f) The office must issue a medical cannabis retailer endorsement to a cannabis license holder if the license holder:

(1) submits a medical cannabis retail endorsement application to the office;

(2) has at least one employee who earned a medical cannabis consultant certificate issued by the office and has completed the required training or has at least one employee who is a licensed pharmacist under chapter 151; and

(3) otherwise meets all applicable requirements established by the office.

(g) A medical cannabis retail endorsement entitles the license holder to purchase medical cannabis flower and medical cannabinoid products from cannabis businesses with medical cannabis cultivator endorsements and medical cannabis processor endorsements, and sell or distribute medical cannabis flower, medical cannabinoid products, and associated paraphernalia to any person authorized to receive medical cannabis flower or medical cannabinoid products.

(h) A medical cannabis business with a medical cannabis retail endorsement must verify that all medical cannabis flower and medical cannabinoid products have passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower and medical cannabinoid products before the cannabis business with a medical cannabis retail endorsement may distribute the medical cannabis flower or medical cannabinoid product to any person enrolled in the registry program.